Prot # EXC 001-201: A Phase 2, Randomized, Double-Blind, Within-Subject Controlled, Dose Ranging Study to Evaluate Efficacy and Safety of EXC 001 for the Treatment of Incision Scars in the Pannus of Subjects Undergoing an Elective Abdominoplasty

Project: Research project

Project Details

Effective start/end date12/16/0912/15/12


  • Excaliard Pharmaceuticals, Inc. (Prot # EXC 001-201)